Hims & Hers Health Inc [NYSE: HIMS] stock went on an upward path that rose over 6.76% on Friday, amounting to a one-week price decrease of less than -23.06%.
Over the last 12 months, HIMS stock rose by 104.34%. The one-year Hims & Hers Health Inc stock forecast points to a potential downside of -95310036.16. The average equity rating for HIMS stock is currently 2.64, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $11.06 billion, with 215.21 million shares outstanding and 190.70 million shares in the current float. Compared to the average trading volume of 44.10M shares, HIMS stock reached a trading volume of 83186675 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Hims & Hers Health Inc [HIMS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIMS shares is $46.27 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIMS stock is a recommendation set at 2.64. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Hims & Hers Health Inc shares, keeping their opinion on the stock as Hold, with their previous recommendation back on June 23, 2025. While these analysts kept the previous recommendation, Needham raised their target price from $61 to $65. The new note on the price target was released on June 04, 2025, representing the official price target for Hims & Hers Health Inc stock. Previously, the target price had yet another raise to $30, while TD Cowen analysts kept a Hold rating on HIMS stock. On February 18, 2025, analysts increased their price target for HIMS shares from 42 to 60.
The Price to Book ratio for the last quarter was 20.11, with the Price to Cash per share for the same quarter was set at 1.44. Price to Free Cash Flow for HIMS in the course of the last twelve months was 47.01 with Quick ratio for the last quarter at 1.32.
HIMS Stock Performance Analysis:
Hims & Hers Health Inc [HIMS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.06. With this latest performance, HIMS shares dropped by -7.37% in over the last four-week period, additionally plugging by 79.02% over the last 6 months – not to mention a rise of 104.34% in the past year of trading.
Insight into Hims & Hers Health Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Hims & Hers Health Inc [HIMS] shares currently have an operating margin of 6.48% and a Gross Margin at 68.19%. Hims & Hers Health Inc’s Net Margin is presently recorded at 9.21%.
Return on Equity for this stock inclined to 24.54%, with Return on Assets sitting at 24.54%.
HIMS Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HIMS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hims & Hers Health Inc go to 34.58%.
Hims & Hers Health Inc [HIMS] Institutonal Ownership Details
There are presently around $74.68%, or 84.04% of HIMS stock, in the hands of institutional investors. The top three institutional holders of HIMS stocks are: VANGUARD GROUP INC with ownership of 16.47 million shares, which is approximately 7.6746%. BLACKROCK INC., holding 14.57 million shares of the stock with an approximate value of $$294.25 million in HIMS stocks shares; and BLACKROCK INC., currently with $$121.94 million in HIMS stock with ownership which is approximately 2.814%.
